End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1116 USD | +0.36% | +5.28% | -43.64% |
Apr. 11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 13 | Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors | CI |
Business Summary
Number of employees: 12
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccine Discovery and Development
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| - | - | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ralph Schiess
CEO | Chief Executive Officer | 46 | Dec. 14 |
Bruce Harmon
DFI | Director of Finance/CFO | 66 | 23-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
BRD | Director/Board Member | 62 | Feb. 05 |
Ajit Singh
BRD | Director/Board Member | 60 | Feb. 06 |
James Sapirstein
CHM | Chairman | 63 | - |
Timothy Ramdeen
BRD | Director/Board Member | 32 | 22-12-31 |
Simon Tarsh
BRD | Director/Board Member | 63 | 22-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,845,100 | 17,754,358 ( 77.72 %) | 517,399 ( 2.265 %) | 77.72 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-43.64% | 3.48M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- ONCO Stock
- Company Onconetix, Inc.